Back

Persistence and compliance amongst sacubitril/valsartan patients in germany, a retrospective cohort study from a longitudinal pharmacy database

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Patient management - From oral treatment to transplant Pharmacotherapy HFA Premium Access Heart Failure 2018

About the speaker

Photo
Ms Sara Bruce Wirta

Novartis Sweden AB, Stockholm (Sweden)

14 More presentations in this session

Presentation thumbnail
Structured follow-up program of patients with heart failure: impact on quality of life and prognosis.
Doctor J. AGOSTINHO (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Impact of physicians' adherence to guideline-recommended therapy on heart failure re-hospitalizations: data from the Optimize Heart Failure Care Program
Doctor A. Grebennikova (Volgograd, RU)
Abstract Slides Video
Presentation thumbnail
Perceptions of heart failure treatment decision-making and side effects of heart failure treatment by patients and cardiologists: a multinational survey in the real-world cardiology setting
Doctor S. Bruce Wirta (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
CANCELLED - The effect of home-based cardiac rehabilitation following coronary artery bypass graft surgery in a low income country: A controlled trial
Mr J. Uddin (Dhaka, BD)
Abstract
Presentation thumbnail
The optimal plasma volume status in heart failure in relation to clinical outcome
Doctor P. Martens (Genk, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Patient management - From oral treatment to transplant

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources